About Pharmaceutical Formulation Market
A pharmaceutical formulation refers to a composition of active chemical substances such as APIs are combined to produce a medical drug by using appropriate excipients and technological procedures. Each inactive substance used to make the formulation is included to fulfill a specific purpose. The spend momentum of this market will be attributed to the growing demand for biologics for the treatment of chronic diseases such as cancer, Alzheimer’s, diabetes, arthritis, and dementia.
Covered in this report
The report provides actionable insights to improve source-to-contract cycle performance in the Global Pharmaceutical Formulation Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report, Global Pharmaceutical Formulation Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Category driver
Category management strategy
Procurement best practices
Key questions answered in this report
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
A pharmaceutical formulation refers to a composition of active chemical substances such as APIs are combined to produce a medical drug by using appropriate excipients and technological procedures. Each inactive substance used to make the formulation is included to fulfill a specific purpose. The spend momentum of this market will be attributed to the growing demand for biologics for the treatment of chronic diseases such as cancer, Alzheimer’s, diabetes, arthritis, and dementia.
Covered in this report
The report provides actionable insights to improve source-to-contract cycle performance in the Global Pharmaceutical Formulation Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.
The report, Global Pharmaceutical Formulation Market, provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.
Category driver
- Increase in demand for pediatric and specialty drugs
Category management strategy
- Collaborate with service providers that offer supply assurance
Procurement best practices
- Application of DOE for formulation development
Key questions answered in this report
- What are the market dynamics?
- What are the key market trends?
- What are the category growth drivers?
- What are the constraints on category growth?
- Who are the suppliers in this market?
- What are the demand-supply shifts?
- What are the major category requirements?
- What are the procurement best practices in this market?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: MARKET INSIGHTS
PART 03: CATEGORY PRICING INSIGHTS
PART 04: COST-SAVING OPPORTUNITIES
PART 05: BEST PRACTICES
PART 06: CATEGORY ECOSYSTEM
PART 07: CATEGORY MANAGEMENT STRATEGY
PART 08: CATEGORY MANAGEMENT ENABLERS
PART 09: SUPPLIERS SELECTION
PART 10: SUPPLIERS UNDER COVERAGE
PART 11: US MARKET INSIGHTS
PART 12: CATEGORY DEFINITION
PART 13: APPENDIX
Executive Summary
The following companies as the key suppliers in the Global Pharmaceutical Formulation Category - Procurement Market Intelligence Report: Merck & Co. Inc, Pfizer Inc, Mylan NV, AstraZeneca Plc, Sanofi, Novartis AG.Commenting on the report, an analyst from the research team said: “One of the procurement best practices for buyers is to establish a robust compliance program with enhanced visibility and adherence to GMP practices. This will help buyers to reduce complexities in managing long supply chains and to minimize the risk of delays due to regulatory issues.”
According to the report, one of the key growth contributors for the global pharmaceutical formulation market is the rise in adoption of biologics for the treatment of chronic diseases.
Further, the report states that one of the key category management strategies for the buyers in the global pharmaceutical formulation market is to rationalize their supply base to attain better spent visibility, thereby reduce scopes of additional cost.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
Companies Mentioned
- Merck & Co. Inc
- Pfizer Inc
- Mylan NV
- AstraZeneca Plc
- Sanofi
- Novartis AG.
Methodology
LOADING...